Which FTC refund programs have returned money for health product scams in the last five years?
Executive summary
Over the last five years the Federal Trade Commission has returned money to consumers through multiple case-specific refund programs tied to deceptive health-product and health-plan marketing — notable examples include refunds for Pure Green Coffee buyers, purchasers of three deceptively marketed supplements (Neurocet, Regenify, Resetigen‑D), large restitution in the Benefytt health‑plan matter, and a string of other settlements and distributions dating from 2021 through 2026 [1] [2] [3]. This report names the principal FTC refund actions documented in the provided reporting, notes the scale of payments when available, and flags where source material limits precise payment timing or individual‑claim processes [4] [5].
1. Pure Green Coffee: a six‑figure refund program for a sham weight‑loss product
The FTC announced a program to send more than $905,000 in refunds to consumers who bought Pure Green Coffee, which regulators say was marketed with false health claims and bogus testimonials; the agency’s health‑fraud pages list that refund as a recent enforcement distribution tied to deceptive weight‑loss advertising [1].
2. Refunds for deceptively marketed supplements (Neurocet, Regenify, Resetigen‑D)
In a case the FTC filed in April 2020 and resolved with a final order in 2021, the Commission distributed refunds totaling more than $1.1 million to consumers who purchased three supplements deceptively marketed as treatments for pain and age‑related conditions; the FTC describes those payments and the underlying order on its press page [2].
3. Large restitution orders in health plan and telemarketing fraud: Benefytt and related schemes
The FTC’s action against Benefytt Technologies produced proposed court orders requiring approximately $100 million in refunds tied to sham health plans and junk fees, a restitution program of markedly larger scale than typical supplement cases; the FTC press material describes the $100 million refund requirement and the permanent bans the order would impose [3].
4. Refunds tied to telemedicine, GLP‑1 and weight‑loss marketing: NextMed and similar settlements
Enforcement against telemedicine sellers of weight‑loss programs has produced consumer refunds; for example, a consent order with NextMed requires $150,000 in refunds to customers and other corrective measures related to deceptive pricing, fake reviews, and misrepresentations about drug access (GLP‑1s) [6]. The FTC’s Health and enforcement pages catalogue similar telemarketing and telemedicine actions that seek consumer refunds [1] [7].
5. CBD, masks, publications and other health‑adjacent refund distributions
The FTC has also returned money to buyers of CBD products (Kushly Industries distributions noted) and to purchasers of a purported N95‑grade face mask (the Zephyr settlement anticipated to provide more than $1.1 million in refunds), and it has sent multi‑million dollar distributions to consumers defrauded by direct‑mail health and finance publications — for example, an FTC mailing of 227,995 checks averaging about $26.57 and a separate refund distribution of 34,893 checks and PayPal refunds totaling more than $2 million tied to a deceptive publications scheme [8] [1] [9].
6. Ongoing claims processes, timing, and limits of available reporting
Several matters are described by the FTC as having active or upcoming claims processes rather than completed mailings: Golden Sunrise and related defendants were subject to court orders and the FTC announced a consumer refund claims process in January 2024 with anticipated mailings in 2026, and other cases list proposed orders or settlements that trigger future refund distributions [10] [4]. The FTC’s “Recent FTC Cases Resulting in Refunds” and enforcement/refunds pages compile these programs but do not always provide precise per‑consumer amounts or final mailing dates in the source excerpts [5] [11].
7. What this pattern shows and what it does not
Taken together, the FTC’s activities over the past five years show sustained use of case‑specific refund programs to return money to customers harmed by false or unproven health claims across supplements, weight‑loss products, telemedicine plans, masks, CBD and direct‑mail schemes — ranging from modest six‑figure distributions to proposed nine‑figure refunds in the Benefytt matter [1] [2] [3]. The reporting supplied, however, is case‑based; it does not present a single unified “health product refund program” name covering all actions, and some entries describe proposed settlements or claims windows rather than completed disbursements, a limitation reflected in the FTC materials [10] [4] [5].
Conclusion
The FTC has repeatedly returned consumer funds in health‑product and health‑plan enforcement actions over the last five years; prominent, documented refund programs named in the provided reporting include distributions for Pure Green Coffee (>$905k), the Neurocet/Regenify/Resetigen‑D supplement case (>$1.1M), the large Benefytt refund obligation (~$100M proposed), NextMed ($150k consent refunds), Kushly/CBD distributions, Zephyr mask refunds (~$1.1M proposed), and multi‑million distributions tied to deceptive publications and continuity product schemes [1] [2] [3] [6] [8] [9]. Where sources describe proposed orders or anticipated mailing dates rather than completed payments, that nuance is reported here as a limitation of the available excerpts [10] [4].